What we choose to study—whether fine art or finance—is one of the most influential decisions in our lives. It shapes not only ...
23andMe and 20 lung cancer advocacy organizations are working to improve lung cancer detection, risk reduction and care. 23andMe, the genetic health and biopharmaceutical company, has partnered with ...
23andMe Research Institute, Troper Wojcicki Philanthropies (TWP), and Lifebit today announced the official launch of an open-source data platform for the Lung Cancer Genetics Study. Launched in 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback